Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy
Abstract With the in-depth exploration on cancer therapeutic nanovaccines, increasing evidence shows that the poor delivery of nanovaccines to lymphoid organs has become the culprit limiting the rapid induction of anti-tumor immune response. Unlike the conventional prophylactic vaccines that mainly...
Enregistré dans:
Auteurs principaux: | Ting Cai, Huina Liu, Shun Zhang, Jing Hu, Lingxiao Zhang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c8efa55ab0ae4d62b5de991db51d14d5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics
par: Menglu Zhu, et autres
Publié: (2021) -
Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery
par: Wenyan Hao, et autres
Publié: (2021) -
Correction to: Co-delivery of nanoparticle and molecular drug by hollow mesoporous organosilica for tumor-activated and photothermal-augmented chemotherapy of breast cancer
par: Haixian Zhang, et autres
Publié: (2021) -
Multifaceted glycoadjuvant@AuNPs inhibits tumor metastasis through promoting T cell activation and remodeling tumor microenvironment
par: Xiaojing Xu, et autres
Publié: (2021) -
Reshaping the Inflammatory Environment in Rheumatoid Arthritis Joints by Targeting Delivery of Berberine with Platelet‐Derived Extracellular Vesicles
par: Qingle Ma, et autres
Publié: (2021)